Literature DB >> 33779485

IL-8, MSPa, MIF, FGF-9, ANG-2 and AgRP collection were identified for the diagnosis of colorectal cancer based on the support vector machine model.

Mingfu Cui1, Yanan Zhao2, Zuocong Zhang3, Yang Zhao4, Songyun Han5, Ruijie Wang6, Dayong Ding1, Xuedong Fang1.   

Abstract

Colorectal cancer (CRC) is one of the most common cancer, and the early detection of CRC is essential to improve the survival rate of patients. To identify diagnostic markers for colorectal cancer (CRC) by screening differentially expressed proteins (DEPs) in CRC. The DEPs were initially obtained from 12 CRC samples and 12 healthy control samples, and verification analysis was performed in another 34 CRC samples and 34 normal controls. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment with DEPs was analyzed by the R package clusterProfiler (Version 3.2.11), and the DEP-associated protein-protein interaction (PPI) network was created from the STRING database. Additionally, Support Vector Machine (SVM) model prediction and survival analyses were conducted on the key DEPs. Preliminary screening and functional analysis showed that the DEPs mainly overrepresented in pathways such as cytokine-cytokine receptor interaction, chemokine signaling pathway, Rap1, Ras, and MAPK signaling pathways. The key DEPs, including AgRP, ANG-2, Dtk, EOT3, FGF-4, FGF-9, HCC-4, IL-16, IL-8, MIF, MSPa, TECK, TPO, TRAIL R3, and VEGF-D, were used to construct a custom chip. The drug-gene interaction network suggested that TPO was a key drug target. ROC curve showed the SVM diagnostic model with the DEPs IL-8, MSPa, MIF, FGF-9, ANG-2, and AgRP had better diagnostic performance with an AUC of 0.933. Survival analysis showed the expression of FGF9, TPO, TRAIL R3, Dtk, TECK and FGF4 were associated with prognosis. This study revealed the important serum proteins in the pathogenesis of CRC, which might serve as useful and noninvasive predictors for the diagnosis of CRC.

Entities:  

Keywords:  Colorectal cancer; diagnosis; differentially expressed proteins; svm model prediction

Mesh:

Substances:

Year:  2021        PMID: 33779485      PMCID: PMC8098075          DOI: 10.1080/15384101.2021.1903208

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  34 in total

Review 1.  Proteomic applications for the early detection of cancer.

Authors:  Julia D Wulfkuhle; Lance A Liotta; Emanuel F Petricoin
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

Review 2.  Machine learning-based coronary artery disease diagnosis: A comprehensive review.

Authors:  Roohallah Alizadehsani; Moloud Abdar; Mohamad Roshanzamir; Abbas Khosravi; Parham M Kebria; Fahime Khozeimeh; Saeid Nahavandi; Nizal Sarrafzadegan; U Rajendra Acharya
Journal:  Comput Biol Med       Date:  2019-07-04       Impact factor: 4.589

3.  Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer.

Authors:  Yuewen Qi; Haowen Qi; Zeyuan Liu; Peiyuan He; Bingqing Li
Journal:  J Comput Biol       Date:  2019-02-27       Impact factor: 1.479

4.  Evaluation of predictive markers for patients with advanced colorectal cancer.

Authors:  Per Byström; Åke Berglund; Peter Nygren; Lisa Wernroth; Birgitta Johansson; Anders Larsson; Bengt Glimelius
Journal:  Acta Oncol       Date:  2012-09       Impact factor: 4.089

5.  miR-340 suppresses tumor growth and enhances chemosensitivity of colorectal cancer by targeting RLIP76.

Authors:  L-L Zhang; F-J Xie; C-H Tang; W-R Xu; X-S Ding; J Liang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-06       Impact factor: 3.507

6.  Id-1 expression in colorectal adenocarcinoma tissues and its clinical significance.

Authors:  Xue-Liang Wu; Yuan-Yuan Wang; Li-Kun Wang; Jun Xue; Dong-Dong Yang; Ming Qu; Chen-Yu Wang; Fei Guo; Rui-Min Yang; Bo Liu
Journal:  Rev Assoc Med Bras (1992)       Date:  2019-04-11       Impact factor: 1.209

7.  Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.

Authors:  Jie Huang; Qi Song; Hao Wang; Haixing Wang; Chen Xu; Xin Wang; Zhengzeng Jiang; Yanqiu Wang; Yifan Xu; Jieakesu Su; Haiying Zeng; Lijie Tan; Hongguang Zhu; Dongxian Jiang; Yingyong Hou
Journal:  Hum Pathol       Date:  2018-06-22       Impact factor: 3.466

Review 8.  Colorectal Cancer Biomarkers: Where Are We Now?

Authors:  Maria Gonzalez-Pons; Marcia Cruz-Correa
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

9.  Screening of feature genes in distinguishing different types of breast cancer using support vector machine.

Authors:  Qi Wang; Xudong Liu
Journal:  Onco Targets Ther       Date:  2015-08-27       Impact factor: 4.147

10.  Hospital-based colorectal cancer survival trend of different tumor locations from 1960s to 2000s.

Authors:  Yu-Jing Fang; Xiao-Jun Wu; Qian Zhao; Li-Ren Li; Zhen-Hai Lu; Pei-Rong Ding; Rong-Xin Zhang; Ling-Heng Kong; Fu-Long Wang; Jun-Zhong Lin; Gong Chen; Zhi-Zhong Pan; De-Sen Wan
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

View more
  1 in total

Review 1.  Escaping cell death via TRAIL decoy receptors: a systematic review of their roles and expressions in colorectal cancer.

Authors:  Kelly Xue Jing Jong; Elsa Haniffah Mejia Mohamed; Zaridatul Aini Ibrahim
Journal:  Apoptosis       Date:  2022-10-07       Impact factor: 5.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.